Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Gastrointestinal (GI) cancer is one of the common causes of cancer-related death worldwide. Chemotherapy and/or immunotherapy are the current treatments, but some patients do not derive clinical benefits. Recently, studies from cancer molecular subtyping have revealed that tumor molecular biomarkers...
Main Authors: | Bilikis Aderonke Abolarinwa, Ridwan Babatunde Ibrahim, Yen-Hua Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/18/4624 |
Similar Items
-
Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer
by: Sabah Nisar, et al.
Published: (2020-12-01) -
Phytochemicals Approach for Developing Cancer Immunotherapeutics
by: Shu-Yi Yin, et al.
Published: (2017-06-01) -
Implications of IDH mutations on immunotherapeutic strategies for malignant glioma
by: Choi, B.D, et al.
Published: (2022) -
Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
by: Haipeng Zhu, et al.
Published: (2021-08-01) -
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
by: Priyanka Hirani, et al.
Published: (2021-08-01)